Dynamics of primary drug resistance in Novokuznetsk

I. B. Viktorova, S. A. Dolgikh, A. L. Khanin, T. A. Jasukevitch (Novokuznetsk, Russian Federation)

Source: Annual Congress 2006 - Epidemiology of drug resistant tuberculosis
Session: Epidemiology of drug resistant tuberculosis
Session type: E-Posters in free access
Number: 181
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. B. Viktorova, S. A. Dolgikh, A. L. Khanin, T. A. Jasukevitch (Novokuznetsk, Russian Federation). Dynamics of primary drug resistance in Novokuznetsk. Eur Respir J 2006; 28: Suppl. 50, 181

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dynamics of primary multidrug drug resistance in Novokuznetsk over 10 years period
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016

Dynamics and character of MBT drug resistance in a specialized urban TB hospital
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010


Secondary drug resistance tuberculosis in Iran
Source: Eur Respir J 2006; 28: Suppl. 50, 586s
Year: 2006

Multidrug resistant pulmonary TB: Characteristics of drug resistance profiles of MBT in Ukraine
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011

Dynamics of MBT drug resistance in a specialized urban TB hospital (Saratov, Russia)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012


Primary and acquired drug resistance in childhood tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005

The association between HIV and antituberculosis drug resistance
Source: Eur Respir J 2008; 32: 718-725
Year: 2008



Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia)
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Prevalance of initial and acquired resistance to antituberculosis drugs in our clinic
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005

Spreading of resistance to group A anti-tuberculosis drugs among TB patients in Astana city
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Primary drug resistance in HIV/tuberculosis patients in two large cities of Siberia
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB
Source: Eur Respir J 2009; 33: 581-585
Year: 2009



Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

Molecular characteristics of resistant to antimicrobials Mycobacterium tuberculosis circulating in Belarus
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010

Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006

Trend of acquired drug resistance to main anti TB drugs in the first 7 years of applying DOT strategy in Iasi County, Romania
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007


Anti-tuberculosis drug resistance in Sivas, Turkey
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007


Increasing anti-tuberculosis drug resistance in the UK
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008

Evaluation the drug susceptibility testing and the prevalence of resistance to antituberculosis drugs in a chronic department
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Antituberculosis drug resistance in a secondary care hospital in Turkey
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007